Kristin Abate, Chief Accounting Officer: Karyopharm Therapeutics KPTI Sell · Filed 01/22

Trade details

Type: Insider sale
Amount: $1,579.4
Shares · price: 265 sh · $5.96 a share
Held after: 22,580 sh
Stock: Karyopharm Therapeutics KPTI
Person: Kristin AbateChief Accounting Officer
Trade date: 26/01/21
Filed: 26/01/22
Days to filing: 1 days

Sold 1.2% of holdings

Share of holding sold: 1.2%

Karyopharm Therapeutics trades, last 26 weeks

What else happened in Karyopharm Therapeutics around then

Filed or reported within 30 days of the trade day · 25/12/22~02/20

Kristin Abate's recent trades

Kristin AbateChief Accounting Officer
SellKaryopharm Therapeutics
Sell
Karyopharm Therapeutics
KPTI
$504
53 sh
$504
Filed 05/15
Traded 05/14
Kristin AbateChief Accounting Officer
SellKaryopharm Therapeutics
Sell
Karyopharm Therapeutics
KPTI
$5,260
559 sh
$5,260
Filed 03/03
Traded 03/02
Kristin AbateChief Accounting Officer
SellKaryopharm Therapeutics
Sell
Karyopharm Therapeutics
KPTI
$352
50 sh
$352
Filed 01/29
Traded 01/28
Kristin AbateChief Accounting Officer
SellKaryopharm Therapeutics
Sell
Karyopharm Therapeutics
KPTI
$2,281
362 sh
$2,281
Filed 25/10/03
Traded 25/10/01
Kristin AbateChief Accounting Officer
SellKaryopharm Therapeutics
Sell
Karyopharm Therapeutics
KPTI
$148
23 sh
$148
Filed 25/09/16
Traded 25/09/15

Kristin Abate, CAO — sold $1,579 of Karyopharm Therapeutics KPTI · 1.2% of holdings | Whalegun